ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
APRINOIA Announces Approval from NMPA to Initiate Phase 3 Clinical Trial in China for [18F]-APN-1607 Tau PET Imaging Tracer for Dementia
October 29, 2020APRINOIA Therapeutics announced that China National Medical Products Administration (NMPA) had approved to initiate Phase 3 clinical trial to evaluate APRINOIA's positron emission tomography (PET) imaging tracer, [18F]-APN-1607, targeting abnormal tau ... -
PET Helps Tailor Therapy in Limited-Stage DLBCL
December 25, 2019Positron emission tomography (PET)-directed therapy results in excellent outcomes for patients with stage I/II diffuse large B-cell lymphoma (DLBCL) ... -
One Downside of Legalized Pot: Poisoned Pets
July 09, 2019People who use marijuana know that the drug should be kept out of the reach of small children. -
Don't Forget Your Pets in Emergency Plans
July 08, 2019Your beloved pets need to be part of any plan you craft for emergencies, such as hurricanes or floods. -
Myocardial Perfusion PET Predicts Cardiac Death in Diabetes
July 01, 2019Myocardial Perfusion PET Predicts Cardiac Death in Diabetes.
Pharma Sources Insight January 2025
